Exports of Jordan's therapeutic industries grew by 9% to JD809mln in 2024-JCI
Exports of the Kingdom's therapeutic industries sector achieved growth during the year 2024 by 9% to reach approximately JD809 million, constituting about 9% of total industrial exports, Dr. Fadi Atrash, Representative of Therapeutic Industries and Medical Supply Sector in Jordan Chamber of Industry (JCI), announced, Petra reports.
In this context, Atrash referred to the His Majesty King Abdullah's support to the Jordanian pharmaceutical industry, who constantly directs to back the sector's companies and overcome any obstacles facing their operations to maintain growth and keep pace with the world developments.
Additionally, he praised His Majesty's visit to the pharmaceutical company of Dar Aldawa, which manufactures pharmaceutical preparations and healthcare products.
In remarks to "Petra" on Thursday, Atrash noted His Majesty's visit to the company confirms his continuous follow-up on the Kingdom's pharmaceutical industries sector, which is a basic driver of the Economic Modernization Vision, and a high-value industry.
Atrash pointed out that the sector enjoys a high added value of up to 55% of total production, or 850% million.
The Kingdom, he noted, has many export opportunities to various countries of the world in many industrial sectors, primarily therapeutic industries and medical supplies, which were estimated at more than JD515 million to various countries.
"As a result of the successive developments in the performance of Jordan's pharmaceutical industries, the added value of the industry has increased significantly and has reached more than 51% of the total existing production of the sector," he pointed out.
These developments, he stated, have had a "positive" impact on the sector's contribution to the national economy, which amounts to about 3% of the Kingdom's total GDP, while its products are present in 85 export markets, primarily Saudi Arabia, Iraq, the United States of America, the Emirates, Algeria and Yemen.
Attrash indicated that the Kingdom's human pharmaceutical industry represents 85% of the total therapeutic industries and medical supplies sector.
Atrash noted this industry operates 27 facilities countrywide with a registered capital estimated at about JD280 million, providing 10,000 jobs, 35% of which are occupied by women.
Earlier it was reported that Jordan's Social Security Investment Fund had reported a 9.1% growth in its assets in 2024, amounting to JOD 1.3 billion. The fund’s total assets reached JOD 16.1 billion by the end of 2024, compared to JOD 14.8 billion in 2023.
